Key Facts
- CAS
- 159519-65-0
- Molecular Weight (MW)
- 4491.4 g/mol
- Half-life
- ~3.8 hours (sc)
- Unit
- mcg
- Administration Route
- Subcutaneous
- Frequency
- Twice daily
- Last updated
- 12/14/2025
Overview
—
Protocol
- Dosage Range
- 90 mg twice daily
- Frequency
- Twice daily
- Cycle
- Long-term use as part of antiretroviral regimen
- Administration Route
- Subcutaneous
- Reconstitution Guide
- Reconstitute 90 mg vial with 1.1 mL sterile water for injection
Science
Mechanism of Action
Mechanism of action not fully established in publicly available sources.
Studies are being curated for this entry.
Suggest a studyBenefits
Therapeutic benefits not fully established.
Potential Side Effects
- Side effects not fully established.
References
- FDA Label - FuzeonExternal link · Year —